Effects of Functional Foods on Blood Sugar Levels and Gut Health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study investigates how functional foods influence postprandial glucose levels and gut microbiota in adults aged 18 to 60. Over a 42-day period, participants will undergo three phases: 14 days without intervention, 14 days with functional food supplementation, and another 14 days without intervention. Continuous glucose monitoring will track glucose levels every 15 minutes, while changes in gut microbiota and urine metabolites will also be assessed. The goal is to understand how these interventions can modify glycemic responses.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and female
* Adults between 18 and 60 years of age.
* The signing of the informed consent.

Exclusion Criteria:

* Patients with any type of diabetes.
* Patients with high blood pressure.
* Patients with acquired diseases secondarily producing obesity and diabetes.
* Patients who have suffered a cardiovascular event.
* Patients with gastrointestinal diseases.
* Weight loss \> 3 kg in the last 3 months.
* Catabolic diseases such as cancer and acquired immunodeficiency syndrome.
* Pregnancy status.
* Drug treatment:

  * Antihypertensive drugs or treatment (thiacycline, loop or potassium-sparing diuretics, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, alpha blockers, calcium antagonists, beta blockers).
  * Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or insulin and antidiabetic drugs.
  * Treatment with statins, fibrates or other drugs to control dyslipidemia.
  * Use of antibiotics in the three months prior to the study.
  * Use of steroid drugs, chemotherapy, immunosuppressants, or radiation therapy.
  * Anorexigenic or that accelerate weight loss such as sibutramine or orlistat.
  * Supplements with any of the functional foods used in the study.
  * Probiotic, prebiotic or symbiotic supplements.

Where it's running

• Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  Mexico City, Mexico City, Mexico Recruiting

Study contacts

• Principal investigator: Armando R Tovar, Doctor — Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran
• Study coordinator: Armando R Tovar, Doctor
• Email: tovar.ar@gmail.com
• Phone: 52 5554870900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registering medical data and care outcomes for ALS, SMA, and other motor disorders

  This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.

  Recruiting Ambulanzpartner Soziotechnologie APST GmbH · Berlin, State of Berlin · NCT07900672

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• Orforglipron for Type 2 Diabetes in Ramadan Fasters

  This study tests whether orforglipron helps people with type 2 diabetes who fast during Ramadan, to see if it improves blood sugar control safely.

  Recruiting at 33 sites Phase 3 Eli Lilly and Company · Agra and 39 other locations · NCT07613307

• Long-term weight loss using a galactooligosaccharide (GOS) chewing gum

  This study will see if a chewing gum containing galactooligosaccharides (GOS) helps adults with overweight (BMI >25) lower their weight and change their oral and gut microbiomes.

  Recruiting University of Bern · Bern · NCT07036692

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.